Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome

Published:2011-02-11 Issue:7 Volume:60 Page:902-914
ISSN:0017-5749
Container-title:Gut
language:en
Short-container-title:Gut

Author:

Jeppesen P. B.,Gilroy R.,Pertkiewicz M.,Allard J. P.,Messing B.,O'Keefe S. J.

Publisher

BMJ

Subject

Gastroenterology

Cited by 365 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The real-world analysis of adverse events with teduglutide: a pharmacovigilance study based on the FAERS database;Frontiers in Pharmacology;2024-09-12

2. GLP-2 ameliorates D-galactose induced muscle aging by IGF-1/Pi3k/Akt/FoxO3a signaling pathway in C2C12 cells and mice;Archives of Gerontology and Geriatrics;2024-09

3. The Stem Cell Niche in Short Bowel Syndrome;Gastroenterology Clinics of North America;2024-09

4. Prognostic factor of patients with short bowel syndrome due to nonCrohn disease: A single institution observational study;Medicine;2024-08-30

5. Pancreatitis Associated With Teduglutide: A Disproportionality Analysis via the Food and Drug Administration Adverse Event Reporting System (FAERS) Database;Cureus;2024-08-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP